News
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
London stocks drifted lower in early trade on Friday as Donald Trump’s 9 July tariff deadline loomed, with trading expected ...
The Cambridge, England-based pharmaceutical company said Imfinzi has been approved in the EU for treatments in adults with resectable muscle-invasive bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results